Are polyfluoroalkyl chemicals associated with raised levels of serum testosterone in women with and without Polycystic Ovary Syndrome, undergoing controlled ovarian hyperstimulation IVF cycle

被引:0
|
作者
Cunningham, T. [1 ]
Drage, D. [2 ]
Allgar, V. [3 ]
Kilpatrick, E. [4 ]
Maguiness, S. [1 ]
Mueller, J. [2 ]
Atkin, S. [5 ]
Sathyapalan, T. [6 ]
机构
[1] Hull IVF Unit, Kingston Upon Hull, N Humberside, England
[2] Univ Queensland, Natl Res Ctr Environm Toxicol, Brisbane, Qld, Australia
[3] Hull York Med Sch, Dept Stat, Kingston Upon Hull, N Humberside, England
[4] Sidra Med & Res Ctr, Doha, Qatar
[5] Weill Cornell Med, Res, Doha, Qatar
[6] Hull York Med Sch, Ctr Cardiovasc & Metab Res, Kingston Upon Hull, N Humberside, England
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
P-752
引用
收藏
页码:453 / 454
页数:2
相关论文
共 50 条
  • [1] Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
    Sun, Bo
    Ma, Yujia
    Li, Lu
    Hu, Linli
    Wang, Fang
    Zhang, Yile
    Dai, Shanjun
    Sun, Yingpu
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 11
  • [2] Serum Albumin Levels in Women With Ovarian Hyperstimulation Syndrome With or Without Polycystic Ovaries
    Alserri, Abdulrahman
    Holzer, Hananel
    Tulandi, Togas
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2012, 34 (09) : 866 - 869
  • [3] The dydrogesterone and FSH protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation in IVF/ICSI cycle
    Gurbuz, A. S.
    Gode, F.
    [J]. HUMAN REPRODUCTION, 2019, 34 : 107 - 107
  • [4] Does the phenotype of polycystic ovary syndrome influence the ovarian response to controlled ovarian hyperstimulation for IVF?
    Robin, G.
    Grysole, C.
    Uk, A.
    Barbotin, A. L.
    Decanter, C.
    Dewailly, D.
    [J]. HUMAN REPRODUCTION, 2018, 33 : 466 - 467
  • [5] Serum sex hormone-binding globulin (SHBG) levels during controlled ovarian hyperstimulation as a predictor of ovarian response in women without polycystic ovary syndrome
    Zhai, J.
    Li, S.
    Zhu, Y.
    Chen, Z. J.
    Du, Y.
    [J]. HUMAN REPRODUCTION, 2020, 35 : I393 - I394
  • [6] Controlled ovarian hyperstimulation in women with polycystic ovarian syndrome with or without intrauterine insemination
    Wiser, Amir
    Shalom-Paz, Einat
    Reinblatt, Shaune Leigh
    Holzer, Hananel
    Tulandi, Togas
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (07) : 502 - 504
  • [7] Serum retinol-binding protein-4 levels in polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in-vitro fertilization cycle
    Orvieto, R.
    Shuhat, V.
    Liberty, G.
    Homburg, R.
    Anteby, E. Y.
    Nahum, R.
    Rabinson, J.
    Meltcer, S.
    [J]. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2010, 37 (02): : 100 - 104
  • [8] Endocrine disrupting agents are present in the serum of women with and without polycystic ovary syndrome undergoing IVF in the UK
    Cunningham, T.
    Drage, D.
    Allgar, V
    Kilpatrick, E.
    Maguiness, S.
    Mueller, J.
    Atkin, S.
    Sathyapalan, T.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 : 71 - 72
  • [9] Changes in Coagulation and Fibrinolytic Indices in Women with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation
    Huang, Ying
    Zhao, Yong
    Yan, Ling
    Chuai, Yun-Hai
    Liu, Ling-Ling
    Chen, Yi
    Li, Min
    Wang, Ai-Ming
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
  • [10] Serum bisphenol A concentrations correlate with serum testosterone levels in women with polycystic ovary syndrome
    Konieczna, Aleksandra
    Rachon, Dominik
    Owczarek, Katarzyna
    Kubica, Pawel
    Kowalewska, Agnieszka
    Kudlak, Blazej
    Wasik, Andrzej
    Namiesnik, Jacek
    [J]. REPRODUCTIVE TOXICOLOGY, 2018, 82 : 32 - 37